iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Purchased by Nuveen Asset Management LLC

Nuveen Asset Management LLC raised its holdings in iRhythm Technologies, Inc. (NASDAQ:IRTC – Get Rating) by 4.8% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 129,539 shares of the company’s stock after acquiring an additional 5,949 shares during the period. Nuveen Asset Management LLC’s holdings in iRhythm Technologies were worth $16,228,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the business. Sands Capital Management LLC boosted its position in shares of iRhythm Technologies by 0.9% in the second quarter. Sands Capital Management LLC now owns 3,051,447 shares of the company’s stock worth $329,648,000 after acquiring an additional 26,689 shares during the last quarter. Vanguard Group Inc. grew its stake in shares of iRhythm Technologies by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 2,714,221 shares of the company’s stock valued at $427,409,000 after buying an additional 33,521 shares during the period. BlackRock Inc. increased its holdings in shares of iRhythm Technologies by 0.4% during the 1st quarter. BlackRock Inc. now owns 2,093,147 shares of the company’s stock worth $329,607,000 after buying an additional 8,440 shares during the last quarter. Capital Research Global Investors raised its position in shares of iRhythm Technologies by 60.9% in the 1st quarter. Capital Research Global Investors now owns 1,411,300 shares of the company’s stock worth $222,237,000 after buying an additional 534,300 shares during the period. Finally, Mackenzie Financial Corp boosted its holdings in iRhythm Technologies by 3.2% in the second quarter. Mackenzie Financial Corp now owns 1,213,429 shares of the company’s stock valued at $131,087,000 after acquiring an additional 37,587 shares during the last quarter. Hedge funds and other institutional investors own 98.96% of the company’s stock.

iRhythm Technologies Trading Up 0.4 %

Shares of IRTC opened at $118.93 on Monday. The business’s 50-day moving average price is $103.17 and its 200 day moving average price is $115.48. The company has a current ratio of 3.24, a quick ratio of 3.07 and a debt-to-equity ratio of 0.15. iRhythm Technologies, Inc. has a 1-year low of $85.74 and a 1-year high of $169.54. The stock has a market capitalization of $3.59 billion, a P/E ratio of -30.57 and a beta of 1.41.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on IRTC. Canaccord Genuity Group increased their target price on shares of iRhythm Technologies from $135.00 to $143.00 and gave the stock a “buy” rating in a research report on Friday, February 24th. Truist Financial cut their target price on shares of iRhythm Technologies from $167.00 to $153.00 and set a “buy” rating on the stock in a research note on Tuesday, December 20th. Citigroup decreased their price target on shares of iRhythm Technologies from $144.00 to $110.00 and set a “neutral” rating for the company in a research report on Monday, December 12th. Morgan Stanley raised their price objective on iRhythm Technologies from $128.00 to $130.00 and gave the company an “overweight” rating in a research report on Friday, February 24th. Finally, Needham & Company LLC lowered their target price on iRhythm Technologies from $140.00 to $133.00 and set a “buy” rating for the company in a research note on Friday, February 24th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $146.36.

Insider Activity at iRhythm Technologies

In related news, COO Douglas Devine sold 3,518 shares of the business’s stock in a transaction on Tuesday, February 28th. The shares were sold at an average price of $117.84, for a total transaction of $414,561.12. Following the transaction, the chief operating officer now owns 31,039 shares of the company’s stock, valued at $3,657,635.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other iRhythm Technologies news, COO Douglas Devine sold 3,518 shares of the stock in a transaction dated Tuesday, February 28th. The shares were sold at an average price of $117.84, for a total transaction of $414,561.12. Following the sale, the chief operating officer now owns 31,039 shares of the company’s stock, valued at approximately $3,657,635.76. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Daniel G. Wilson sold 1,726 shares of iRhythm Technologies stock in a transaction that occurred on Tuesday, February 28th. The stock was sold at an average price of $117.84, for a total transaction of $203,391.84. Following the sale, the executive vice president now owns 40,759 shares of the company’s stock, valued at approximately $4,803,040.56. The disclosure for this sale can be found here. In the last 90 days, insiders sold 7,157 shares of company stock valued at $843,381. Insiders own 1.64% of the company’s stock.

iRhythm Technologies Company Profile

(Get Rating)

iRhythm Technologies, Inc engages in the development of monitoring and diagnostic solutions for detection of cardiac arrhythmias. It offers Zio XT, is a wearable patch-based biosensor, which continuously records and stores ECG data from every patient heartbeat for up to 14 consecutive days, and Zio AT, which provides ECG data but also provides physicians with actionable notifications during the wear period.